FL115

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameFL115
Drug Alias NameFL115FL-115
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionInterleukin-15 receptor subunit alpha agonists
TargetsInterleukin-15 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Forlongbiotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSuzhou Forlongbiotech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A